Discover Thomson Reuters
Strong sales of Prevnar helped the drug maker more than double its quarterly profit. As Fred Katayama reports, one analyst called the results "refreshingly boring."
01:00
02:10
01:45
07:21
01:58
01:29
02:07
01:53
02:09
01:49
01:05
00:37
01:10
01:46
01:13
01:37
01:36
01:42
01:57